\
&
Contact us
\
&
Contact us
This was 5 months ago
LocationBrussels or online
The European Institute for Innovation and Technology (EIT) has recently launched a call to join the new knowledge and innovation community (KIC) on water. A KIC is a community where the three sides of the so-called "Knowledge Triangle" (education, research and innovation achieved by industry) come together in order to create succesful innovative businesses and upskill the workforce of the future.
To inform all interested parties about this call, the EIT organises an online information session on the 5th of March. This is part of the European Ocean Days 2025, organised by the European Commission’s Directorate-General for Maritime Affairs and Fisheries (DG MARE).
If you want to follow it online you do not need to register and the streaming link will be published on this website. However if you want to be present in person you need to register here. There is only one participant per organisation allowed so it is best to register as soon as possible. The deadline for registration is the 28th of February.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
